Ulrich Medica USA earned FDA clearance to expand indications for its Momemtum and Momentum minimally invasive posterior spine systems, the company said Dec. 20.
The clearances will let the systems be used in conjunction with G21 V-STEADY Radiopaque bone cement, according to a news release.
The systems are used to provide stabilization, fixation and correction in the thoracolumbar and sacroiliac spine.